Blood Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States

Not Applicable

Terminated

• Conditions: Non Hodgkin's Lymphoma; Aplastic Anemia; Leukemia
• Interventions: Procedure: Megadose T-cell Depleted HLA-nonidentical Blood Progenitor Cell Transplantation

• Registration Number: NCT00038779
• Lead Sponsor: M.D. Anderson Cancer Center

Brief Summary

The purpose of this study is to assess early treatment failure within 100 days and to assess the effect of this regimen on engraftment, GVHD, immune recovery, relapse of malignancy and survival.

Detailed Description

Not available

Study Timeline

• Study Start: 1996-08-14
• Study First Submitted: 2002-06-05
• Study First Submitted QC: 2002-06-06
• Study First Posted: 2002-06-07
• Primary Completion: 2004-09-20
• Study Completion: 2004-09-20
• Status Verified: 2018-10
• Last Update Submitted: 2018-10-29
• Last Update Posted: 2018-10-30

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 7

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Megadose T cell depleted	Megadose T-cell Depleted HLA-nonidentical Blood Progenitor Cell Transplantation	-

Trial Locations

Locations (1)

MD Anderson Cancer Center; 🇺🇸 Houston, Texas, United States